Pioneering Early Dementia Detection
Digital Vision & Non-Invasive Screening
Stay tuned for the latest news on Cognes
Transforming Dementia detection and diagnosis
Early detection is the key to improving the lives of those suffering from one of the many kinds of dementia. Our mission is to empower healthcare providers, researchers, and individuals with the ability to detect dementia early on.
Digital innovation that fits in your pocket
Successful early screening of digital biomarkers of dementia can radically transform dementia care with a digital screening solution powered by machine-learning image-based analysis, hosted on any mobile device, and available to anyone.
A new standard of preventive dementia care
Aligned with public health strategies, we are revolutionizing dementia care through a scalable, innovative, accessible, and efficient screening that can be monitored over time.
The Goal
"Aiming to Revolutionize Global Healthcare Through Digital Innovation"
Our mission is to leverage cutting-edge digital technologies, such as machine learning and computer vision, to democratize healthcare access worldwide. By fostering cross-border collaborations, we are committed to developing advanced screening solutions that mitigate the onset of cognitive decline through early detection and timely interventions.
The Impact
"Transforming Lives and Healthcare Systems Through Cognitive Health Solutions"
Our innovative approaches in digital healthcare are not just groundbreaking—they have the potential to save lives and transform healthcare systems globally. By focusing on the early detection of indicators of cognitive decline, including dementia, we are opening new doors for preventive healthcare. This enables timely interventions that can dramatically improve the quality of life for patients while fostering sustainable growth for communities around the world.
Check out our latest blog posts
Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals
Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals Cognes Medical Solutions is thrilled to announce its selection
Cognes to Entrepreneurship World Cup Top 250
Cognes Medical Solutions Advances to Next Phase of the Entrepreneurship World Cup
Company will compete for a trip to the Global Finals and a share of $US1M in cash prizes
Alzheimer’s Treatment Assessment: Innovative Strategies for Optimal Results
Alzheimer’s disease, a formidable adversary in the realm of neurodegenerative diseases, affects millions worldwide, presenting a significant challenge to both those diagnosed and their loved
Machine-learning tool for scalable early dementia detection.
Cognes is designed with user simplicity in mind. The process of capturing relevant data is seamless, making it accessible to users of all ages and technical backgrounds.